XLO

NASDAQ · Biotechnology

Xilio Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.54

+0.02 (+4.04%)

As of Feb 8, 2:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +9,132.8% upside

Low Target $27.43

Average Target $49.94

High Target $65.11

Current Price $0.54

Current
$0.54

Target
$49.94

$27.43 $49.94 avg $65.11

Scenario Analysis

Bear Case

$27.43

4,971.2%

Low target

Base Case

$49.94

+9,132.8%

Avg target

Bull Case

$65.11

+11,937.3%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$52.16

-99.0% from high

52-Week Low

$30.67

+-98.2% from low

Target vs 52W High

$49.94

-4.3% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-0.12

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%